Psychedelics Investing WEDNESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Medical Device Investing Avricore Health Signs Master Agreement to Pilot HealthTab Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
Psychedelics Investing COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
Medical Device Investing Medtronic Gains FDA Clearance of UNiD Patient-Specific Rods for Use with CD Horizon Solera Voyager and Infinity OCT Spinal Systems
Naturally Splendid Secures 10-Year Exclusive Manufacturing and Distribution Rights To Popular Plant Protein, Meat Alternative Line
Lexaria's DehydraTECH-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus
HempFusion Launches Private Label Business Division, Awarded 10 SKU Private Label Deal with Leading National Retailer
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
